ELIZABETH RUSSEAU: Open Payments
NPI 1508351396 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 12 payments from 9 companies in 2025. Trend: 2023 $833 · 2024 $647 · 2025 $275
Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $60 |
| Amgen Inc. | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| GENZYME CORPORATION | 1 | $31 |
| Janssen Biotech, Inc. | 1 | $27 |
| Incyte Corporation | 1 | $27 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $21 |
| Journey Medical Corporation | 1 | $18 |
| UCB, Inc. | 1 | $16 |
Products named: DUPIXENT, SKYRIZI, OTEZLA, TREMFYA, OPZELURA, Odomzo, RINVOQ, Bimzelx.
Industry payments across IL — which companies pay providers there.
